{"title":"Change in Age of Diagnosis and Demographics of Type 1 Diabetes Mellitus During the COVID-19 Era.","authors":"Katya Sracic, Naveen Uli, Ryan Heksch","doi":"10.1155/pedi/7276579","DOIUrl":null,"url":null,"abstract":"<p><p>Since COVID-19 onset, pediatric endocrinologists have been making an assumption that there was a shift in diagnosis age of type 1 diabetes mellitus (T1DM) to younger children. Younger children are more likely to present in DKA, are more difficult to diagnose and treat, and age at diagnosis can affect prognosis. We performed a retrospective chart review of patients diagnosed with T1DM for 3 years before COVID-19 and the 3 years during COVID-19. Demographics were evaluated using the Chi-squared test for categorical data and Student's <i>t</i>-test or ANOVA for continuous data. During this time, 698 patients were diagnosed with T1DM, with more patients during COVID-19. The average age of diagnosis significantly increased by 0.7 years (<i>p</i>=0.025). There was a significant difference in the distribution of age groups between the two time periods (<i>p</i>=0.0065). There was a significant decrease in new cases among patients between the ages of 2-5 years from 2017 to 2020, a transient finding as they reverted back to previous rates by 2022. New diagnoses between 13 and 18 years were increasing prior to 2020 (7%-23%), subsequently leveling out. Patients were 1.6 times more likely to present in DKA during COVID-19; however, there was no significant change in hemoglobin A1c (HbA1c). There was no significant change in thyroperoxidase (TPO) antibody positivity. There was a significant decrease (<i>p</i>=0.018) in patients with elevated tissue transglutaminase (TTG)-IgA from pre-COVID to post-COVID. Average age at diagnosis in our cohort increased since the start of COVID-19, contradicting previous studies and our hypothesis. The number of new cases increased, and the age distribution changed. There was a significant decrease in number of younger patients in 2020, followed by a normalization of new cases in those 2-5 years old, which may have led to the belief that more toddlers were being diagnosed. The rate of other antibodies did not increase. These results illustrate that changes in demographics may have been short-lived post-COVID-19.</p>","PeriodicalId":19797,"journal":{"name":"Pediatric Diabetes","volume":"2025 ","pages":"7276579"},"PeriodicalIF":1.9000,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549198/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/pedi/7276579","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Since COVID-19 onset, pediatric endocrinologists have been making an assumption that there was a shift in diagnosis age of type 1 diabetes mellitus (T1DM) to younger children. Younger children are more likely to present in DKA, are more difficult to diagnose and treat, and age at diagnosis can affect prognosis. We performed a retrospective chart review of patients diagnosed with T1DM for 3 years before COVID-19 and the 3 years during COVID-19. Demographics were evaluated using the Chi-squared test for categorical data and Student's t-test or ANOVA for continuous data. During this time, 698 patients were diagnosed with T1DM, with more patients during COVID-19. The average age of diagnosis significantly increased by 0.7 years (p=0.025). There was a significant difference in the distribution of age groups between the two time periods (p=0.0065). There was a significant decrease in new cases among patients between the ages of 2-5 years from 2017 to 2020, a transient finding as they reverted back to previous rates by 2022. New diagnoses between 13 and 18 years were increasing prior to 2020 (7%-23%), subsequently leveling out. Patients were 1.6 times more likely to present in DKA during COVID-19; however, there was no significant change in hemoglobin A1c (HbA1c). There was no significant change in thyroperoxidase (TPO) antibody positivity. There was a significant decrease (p=0.018) in patients with elevated tissue transglutaminase (TTG)-IgA from pre-COVID to post-COVID. Average age at diagnosis in our cohort increased since the start of COVID-19, contradicting previous studies and our hypothesis. The number of new cases increased, and the age distribution changed. There was a significant decrease in number of younger patients in 2020, followed by a normalization of new cases in those 2-5 years old, which may have led to the belief that more toddlers were being diagnosed. The rate of other antibodies did not increase. These results illustrate that changes in demographics may have been short-lived post-COVID-19.
期刊介绍:
Pediatric Diabetes is a bi-monthly journal devoted to disseminating new knowledge relating to the epidemiology, etiology, pathogenesis, management, complications and prevention of diabetes in childhood and adolescence. The aim of the journal is to become the leading vehicle for international dissemination of research and practice relating to diabetes in youth. Papers are considered for publication based on the rigor of scientific approach, novelty, and importance for understanding mechanisms involved in the epidemiology and etiology of this disease, especially its molecular, biochemical and physiological aspects. Work relating to the clinical presentation, course, management and outcome of diabetes, including its physical and emotional sequelae, is considered. In vitro studies using animal or human tissues, whole animal and clinical studies in humans are also considered. The journal reviews full-length papers, preliminary communications with important new information, clinical reports, and reviews of major topics. Invited editorials, commentaries, and perspectives are a regular feature. The editors, based in the USA, Europe, and Australasia, maintain regular communications to assure rapid turnaround time of submitted manuscripts.